About this event
- Date and time Wed 20 Nov 2019 from 8:45am to 4:00pm
- Location Royal Society of Medicine
- Organised by Gastroenterology and Hepatology
The RSM liver day will explore key advances in our understanding and management of liver disease. Plus a comprehensive review across a wide range of key hepatological conditions.
The meeting will provide a unique forum for consultant hepatologists, gastroenterologists, specialist registrars and clinical nurse specialists to discuss the current challenges and approaches to the management of liver disease.
You will learn:
- The latest therapeutic advances in chronic liver disease
- How to optimise outcome in alcohol-related liver disease
- The latest therapeutic strategies for viral hepatitis
- Optimise management in acute liver failure and the criteria for transplantation
- Review the pathogenesis and management strategy for fatty liver disease
We would like to thank our sponsor(s):
Bayer and Intercept UK & Ireland Ltd
Each of these sponsor(s) has supported this educational meeting through a payment to exhibit with a stand. Please note that none of the companies listed above have had any influence or involvement over the agenda, content or organisation of this meeting.
Agenda
View the programme
Registration, tea and coffee
Welcome and introduction
Session One
Chair: Introduction
Professor Patrick Kennedy, Honorary Consultant Hepatologist, Barts and the London School of Medicine and Dentistry, Queen Mary University of London
Hepatology through the crystal ball
Professor Roger Williams, Consultant Hepatologist, King’s College London
Alcoholic liver disease
Mr Paul Richardson, Consultant Hepatologist, Royal Liverpool NHS Trust
Tea and coffee break
Decompensated liver disease
Dr Alistair O’Brien, Consultant Hepatologist, University College London Hospitals NHS Foundation Trust
NASH
Dr Will Alazawi, Consultant Hepatologist, Barts Health NHS Trust
Lunch
Session two
Chair: Introduction
Professor Patrick Kennedy
Radiological evaluation of the liver, liver reserve pre-surgery and the role of PVE
Dr Dominic Yu, Consultant Radiologist, Royal Free London NHS Foundation Trust
Latest management of cholestatic liver disease
Dr Yiannis Kallis, Consultant Hepatologist, Barts Health NHS Trust
The assessment of liver reserve in cirrhotic and non-cirrhotic patients pre-operatively and post-operative care
Dr Mark McPhail, Senior Lecturer and Consultant in Liver Critical Care in the Institute of Liver Studies, King's College London
New treatments in HBV and HDV
Dr Upkar Gill, NIHR Academic Clinical Lecturer and Honorary Hepatology Registrar, Barts Liver Centre, Centre for Immunobiology, Barts and The London School of Medicine & Dentistry, Queen Mary University of London
Questions and answers
Concluding remarks
Close of meeting
Sponsors
Location
Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom